Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|December 22, 2017
Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014Ellen Pinnow, Sania Amr, Søren M Bentzen, et al.Journal of Occupational and Environmental Medicine|October 14, 2008
Occupation, gender, race, and lung cancerSania Amr, Beverly Wolpert, Christopher A Loffredo, et al.BMC Public Health|June 3, 2014
Knowledge and perceptions of hepatitis C infection and pesticides use in two rural villages in EgyptDoa'a A Saleh, Sania Amr, Irene A Jillson, et al.Annals of Epidemiology|May 21, 2018
Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and raceLisa D Gardner, Christopher A Loffredo PhD, Patricia Langenberg, et al.BMC Public Health|October 9, 2015
Viral transmission risk factors in an Egyptian population with high hepatitis C prevalenceMary Kate Mohlman, Doa'a A Saleh, Sameera Ezzat, et al.Infection Control and Hospital Epidemiology|April 11, 2013
A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteriaAaron S Hess, Michelle Shardell, J Kristie Johnson, et al.Archives of Environmental & Occupational Health|August 13, 2013
Agricultural workers and urinary bladder cancer risk in EgyptSania Amr, Rebecca Dawson, Doa'a A Saleh, et al.International Journal of Cancer|November 22, 2019
Diabetes, metformin and cancer risk in myotonic dystrophy type IRotana Alsaggaf, Ruth M Pfeiffer, Youjin Wang, et al.JNCI Cancer Spectrum|December 18, 2018
Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease SeverityRotana Alsaggaf, Diane Marie M St George, Min Zhan, et al.Substance Use & Misuse|January 29, 2015
Substance use by Egyptian youth: current patterns and potential avenues for preventionChristopher A Loffredo, Dina N K Boulos, Doa'a A Saleh, et al.Pageof 4